Bayer AG (BAYN) - Financial and Strategic SWOT Analysis Review

Date: April 11, 2018
Pages: 84
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B9BD9859156EN
Leaflet:

Download PDF Leaflet

Bayer AG (BAYN) - Financial and Strategic SWOT Analysis Review
Bayer AG (BAYN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Bayer AG (Bayer) carries out the research, development, production and commercialization of products in the areas of human and animal health care, and agriculture. It provides pharmaceuticals for cardiology, women’s healthcare, cancer, hematology, ophthalmologyand other indications. The company's product portfolio includes prescription products, specialty therapeutics, animal health care products, diagnostic imaging equipment, nonprescription (over-the-counter - OTC) products, seeds, crop protection solutions and nonagricultural pest control solutions. Bayer markets its healthcare and crop protection products principally through wholesalers, pharmacies, hospitals and retailers. It operates through a network of subsidiaries in Asia-Pacific, Europe, the US, Latin America, Africa and the Middle East. Bayer is headquartered in Leverkusen, Germany.

Bayer AG Key Recent Developments

Apr 05,2018: Bayer to Showcase Data from Diverse Oncology Pipeline at AACR 2018
Mar 28,2018: Life Science Leaders Gather at Medidata NEXT Basel and Frankfurt to Examine New Opportunities to Improve Clinical Development and Better Patient Lives
Mar 27,2018: Bayer partners with Plug and Play To Address the Rapid Changes in Healthcare
Mar 06,2018: Travelers Partners with Cedars-Sinai, Samsung Electronics America, Bayer and appliedVR to Test Digital Tools in Treatment of Acute Orthopaedic Injuries
Feb 16,2018: Ten years of Bayer support for employees’ volunteering work

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

NOTE: Out of security concerns GlobalData requires using corporate email address.
SECTION 1 - ABOUT THE COMPANY

Bayer AG - Key Facts
Bayer AG - Key Employees
Bayer AG - Key Employee Biographies
Bayer AG - Major Products and Services
Bayer AG - History
Bayer AG - Company Statement
Bayer AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Company Overview
Bayer AG - Business Description
Business Segment: All Other Segments
Overview
Performance
Business Segment: Animal Health
Overview
Performance
Key Stats
Business Segment: Consumer Health
Overview
Performance
Key Stats
Business Segment: Crop Science
Overview
Performance
Key Stats
Business Segment: Pharmaceuticals
Overview
Performance
Key Stats
Geographical Segment: Asia Pacific
Performance
Geographical Segment: Europe, Middle East and Africa
Performance
Geographical Segment: Latin America
Performance
Geographical Segment: North America
Performance
R&D Overview
Bayer AG - Corporate Strategy
Bayer AG - SWOT Analysis
SWOT Analysis - Overview
Bayer AG - Strengths
Bayer AG - Weaknesses
Bayer AG - Opportunities
Bayer AG - Threats
Bayer AG - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES, POWER FINANCIAL DEALS AND ALLIANCES

Bayer AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Bayer AG, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Bayer AG, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Apr 05, 2018: Bayer to Showcase Data from Diverse Oncology Pipeline at AACR 2018
Apr 05, 2018: Bayer to Showcase Data from Diverse Oncology Pipeline at AACR 2018
Mar 28, 2018: Life Science Leaders Gather at Medidata NEXT Basel and Frankfurt to Examine New Opportunities to Improve Clinical Development and Better Patient Lives
Mar 27, 2018: Bayer partners with Plug and Play To Address the Rapid Changes in Healthcare
Mar 06, 2018: Travelers Partners with Cedars-Sinai, Samsung Electronics America, Bayer and appliedVR to Test Digital Tools in Treatment of Acute Orthopaedic Injuries
Feb 16, 2018: Ten years of Bayer support for employees’ volunteering work
Dec 09, 2017: New Therapies Improve Outlook for Bleeding and Clotting Disorders
Dec 04, 2017: NUST MISIS Students Develop an App for Patients with Bronchiectasis
Dec 01, 2017: Bayer invests in differentiated drug pipeline with over 50 projects focused on high unmet medical needs
Nov 30, 2017: Bayer combines pharmaceutical research and development unit

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Bayer AG, Key Facts
Bayer AG, Key Employees
Bayer AG, Key Employee Biographies
Bayer AG, Major Products and Services
Bayer AG, History
Bayer AG, Subsidiaries
Bayer AG, Joint Venture
Bayer AG, Key Competitors
Bayer AG, Ratios based on current share price
Bayer AG, Annual Ratios
Bayer AG, Annual Ratios (Cont.1)
Bayer AG, Annual Ratios (Cont.2)
Bayer AG, Interim Ratios
Bayer AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Bayer AG, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Bayer AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Bayer AG, Performance Chart (2013 - 2017)
Bayer AG, Ratio Charts
Bayer AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Bayer AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

COMPANIES MENTIONED

Pfizer Inc
Novartis AG
Mitsubishi Chemical Corporation
Johnson & Johnson
Huntsman Corp
Heska Corp
GlaxoSmithKline Plc
BASF SE
Allergan Plc
Skip to top


Ask Your Question

Bayer AG (BAYN) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: